Cargando…
Long VITT: A case report
Vaccine-induced immune thrombotic thrombocytopenia (VITT) has been described following adenovirus vector-based COVID-19 vaccines. This condition is associated with important morbidity and mortality following thrombosis related complications. Diagnosis is confirmed based on results of platelet factor...
Autores principales: | Roberge, Guillaume, Carrier, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870606/ https://www.ncbi.nlm.nih.gov/pubmed/36709677 http://dx.doi.org/10.1016/j.thromres.2023.01.017 |
Ejemplares similares
-
Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report
por: Corica, Bernadette, et al.
Publicado: (2021) -
Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis?
por: Medić, Marijana Grgić, et al.
Publicado: (2022) -
Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Roberge, Guillaume, et al.
Publicado: (2022) -
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020) -
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
por: Brüggemann, Renée, et al.
Publicado: (2020)